Well-evidenced

Anastrozole

Anastrozole

AI explanation

Anastrozole is actually a medication, not a peptide, but it's something men often use when they're taking testosterone therapy or other hormones that can throw their system out of balance. Think of it as a chemical brake pedal for estrogen production in your body.

Here's what happens: when you take testosterone, your body has this enzyme called aromatase that acts like a converter, turning some of that testosterone into estrogen. It's like having a currency exchange booth inside you, constantly swapping one hormone for another. While men need some estrogen for healthy bones, heart function, and sex drive, too much can cause problems like breast tissue growth, water retention, and mood swings.

Anastrozole works by essentially blocking those currency exchange booths. It sits on the aromatase enzyme and prevents it from doing its conversion job, which means less of your testosterone gets turned into estrogen. This keeps your estrogen levels from climbing too high while you maintain the benefits of higher testosterone.

The key is using just enough to keep things balanced, not to eliminate estrogen completely. It's like adjusting the volume on a stereo rather than hitting the mute button – you want to find that sweet spot where everything sounds right.

Dosage Information

Typical Dose

0.25-0.5 mg, 2-3 times weekly (TRT adjunct)

Frequency

2-3 times weekly

Morning

Administration

Oral tablet

Half-Life

46–50 hours

Notes

Requires regular estradiol monitoring to avoid over-suppression. Estrogen should be managed into range, not eliminated. Over-suppression causes joint pain, low libido, mood depression, and bone loss.

Why this matters

Long half-life; every-other-day or twice-weekly dosing is common.

Protocol cycle

continuous· TRT adjunct, requires ongoing estradiol monitoring

Where does Anastrozole sit?

See how this peptide compares across all 150 peptides in our database.

Evidence Score

0.78

Clinical trials
1.0035%
Literature
0.9430%
Community
0.0020%
Completeness
1.0015%
6 RCTs2 clinical trials6 reviews

Compound Data

Anastrozole structure

Molecular Formula

C17H19N5

Molecular Weight

293.40 g/mol

IUPAC Name

2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile

PubChem CID

2187

Potential Side Effects

Joint pain and stiffness (common at oncology doses, less so at TRT doses)Hot flashes (common at oncology doses)Bone density loss with long-term use (uncommon at low TRT doses)Mood changes (uncommon)Elevated cholesterol (uncommon)
Pep Talk

Anastrozole discussions

Quick Facts

Administration
Oral tablet
Typical Dose
0.25-0.5 mg, 2-3 times weekly (TRT adjunct)
Frequency
2-3 times weekly
References
0 curated + 46 from PubMed
Clinical Trials
94 registered
Evidence Score
0.8 / 100

Frequently Asked Questions about Anastrozole

What is Anastrozole?

Anastrozole is a third-generation non-steroidal aromatase inhibitor FDA-approved for breast cancer treatment. In the hormonal health community it is widely used off-label to control estrogen levels in men undergoing testosterone replacement therapy or using anabolic compounds that aromatize to estrogen. By inhibiting the enzyme responsible for converting androgens to estrogens, anastrozole allows for management of estrogen-related side effects while maintaining the benefits of androgen optimization. It has a well-established clinical profile from its breast cancer applications and extensive off-label use data.

How does Anastrozole work?

Anastrozole competitively and selectively inhibits aromatase (CYP19A1), the enzyme complex responsible for the biosynthesis of estrogens from androgens. It blocks the conversion of testosterone to estradiol and androstenedione to estrone in peripheral tissues — primarily adipose tissue, liver, and muscle. By reducing circulating estradiol levels, anastrozole mitigates estrogen-dependent side effects including gynecomastia, water retention, and mood changes associated with elevated estrogen. In post-menopausal breast cancer, it starves estrogen-receptor-positive tumors of their growth signal. In TRT contexts it is used at much lower doses than in oncology to maintain estrogen in physiological range rather than suppress it completely — as some estrogen is essential for cardiovascular health, bone density, and libido in men.

What is the recommended dosage for Anastrozole?

The typical dose is 0.25-0.5 mg, 2-3 times weekly (TRT adjunct). 2-3 times weekly. Administration: Oral tablet. Requires regular estradiol monitoring to avoid over-suppression. Estrogen should be managed into range, not eliminated. Over-suppression causes joint pain, low libido, mood depression, and bone loss.

What are the side effects of Anastrozole?

Joint pain and stiffness (common at oncology doses, less so at TRT doses). Hot flashes (common at oncology doses). Bone density loss with long-term use (uncommon at low TRT doses). Mood changes (uncommon). Elevated cholesterol (uncommon)

What is the Anastrozole cycle protocol?

Anastrozole is typically cycled continuous. TRT adjunct, requires ongoing estradiol monitoring

Questions reflect common community inquiries. This is not medical advice.